These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 16617267)

  • 1. What to declare and why?
    Neutra RR
    Epidemiology; 2006 May; 17(3):244-5. PubMed ID: 16617267
    [No Abstract]   [Full Text] [Related]  

  • 2. He who pays the piper, calls the tune....
    Brunekreef B
    Epidemiology; 2006 May; 17(3):246-7. PubMed ID: 16617268
    [No Abstract]   [Full Text] [Related]  

  • 3. Why focus only on financial interests?
    Acquavella JF
    Epidemiology; 2006 May; 17(3):248-9. PubMed ID: 16617269
    [No Abstract]   [Full Text] [Related]  

  • 4. Kafka's truth-seeking dogs.
    Olsen J
    Epidemiology; 2006 May; 17(3):242-3. PubMed ID: 16617266
    [No Abstract]   [Full Text] [Related]  

  • 5. ARVO Commercial Relationships Policy: financial disclosure in ARVO presentations and publications. Association for Research in Vision and Ophthalmology, Inc.
    Novack GD
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2765-6. PubMed ID: 10549632
    [No Abstract]   [Full Text] [Related]  

  • 6. Conflicts of interest and disclosures in publications.
    Camilleri M; Dubnansky EC; Rustgi AK
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):268-73. PubMed ID: 17368225
    [No Abstract]   [Full Text] [Related]  

  • 7. Disclosure of financial interest: the first step.
    Arnold EP
    Neurourol Urodyn; 2007; 26(6):751. PubMed ID: 17600371
    [No Abstract]   [Full Text] [Related]  

  • 8. Journal policies on authorship and disclosures.
    Katz PP; Yelin EH; Lockshin MD
    Arthritis Rheum; 2006 Jun; 55(3):345-7. PubMed ID: 16739200
    [No Abstract]   [Full Text] [Related]  

  • 9. Investigator financial disclosures and its effect on research subjects.
    Gibbs JN; Guagnano GA
    Food Drug Law J; 2007; 62(4):727-37. PubMed ID: 18557228
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical Pharmacology & Therapeutics' conflict of interest policy.
    ;
    Clin Pharmacol Ther; 2007 Nov; 82(5):496-7. PubMed ID: 17952103
    [No Abstract]   [Full Text] [Related]  

  • 11. Conflicts of interest. Cardiologists come under the glare of a Senate inquiry.
    Kaiser J
    Science; 2008 Oct; 322(5901):513. PubMed ID: 18948508
    [No Abstract]   [Full Text] [Related]  

  • 12. Should physicians be expected to disclose conflicts of interest?
    Patterson P
    OR Manager; 2007 May; 23(5):1, 23-4, 29. PubMed ID: 17536624
    [No Abstract]   [Full Text] [Related]  

  • 13. All our dreams our sold.
    Fava GA
    Psychother Psychosom; 1998; 67(4-5):191-3. PubMed ID: 9735020
    [No Abstract]   [Full Text] [Related]  

  • 14. Does Clinical Pharmacology & Therapeutics' conflict of interest policy protect the reader?
    Conway MH
    Clin Pharmacol Ther; 2007 Nov; 82(5):495-6. PubMed ID: 17952102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Financial disclosure is not full disclosure.
    Goldwyn RM
    Plast Reconstr Surg; 1997 Jun; 99(7):2034-5. PubMed ID: 9180728
    [No Abstract]   [Full Text] [Related]  

  • 16. Conflict of interest: a prescription for change.
    McLellan F
    PM R; 2009 Feb; 1(2):99-100. PubMed ID: 19627882
    [No Abstract]   [Full Text] [Related]  

  • 17. Inspector General discusses self-disclosure initiative in open letter.
    Roeder KH; Burnette JP
    GHA Today; 2006; 50(3):3, 9. PubMed ID: 16909749
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of conflict of interest issues in the activities of the American Heart Association Emergency Cardiovascular Care Committee, 2000-2005.
    Billi JE; Eigel B; Montgomery WH; Nadkarni VM; Hazinski MF
    Circulation; 2005 Dec; 112(24 Suppl):IV204-5. PubMed ID: 16314348
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary: Role conflict for the witness consultant.
    Strasburger LH
    J Am Acad Psychiatry Law; 2001; 29(1):46-7. PubMed ID: 11302385
    [No Abstract]   [Full Text] [Related]  

  • 20. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.